Karam JA - Search Results

1

Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM. Karam JA, et al. J Urol. 2011 Feb;185(2):439-44. doi: 10.1016/j.juro.2010.09.086. Epub 2010 Dec 17. J Urol. 2011. PMID: 21167518 Free PMC article.

2

Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate cancer.

Shulman MJ, Karam JA, Benaim EA. Shulman MJ, et al. Among authors: karam ja. Urology. 2004 Apr;63(4):732-6. doi: 10.1016/j.urology.2003.11.016. Urology. 2004. PMID: 15072890

3

Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.

Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH. Shariat SF, et al. Among authors: karam ja. Eur Urol. 2005 Sep;48(3):424-31. doi: 10.1016/j.eururo.2005.04.034. Eur Urol. 2005. PMID: 15963628

4

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.

Svatek R, Karakiewicz PI, Shulman M, Karam J, Perrotte P, Benaim E. Svatek R, et al. Eur Urol. 2006 Apr;49(4):666-74. doi: 10.1016/j.eururo.2005.11.032. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16423446

5

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF. Karam JA, et al. Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009. Urology. 2007. PMID: 17905101

6

Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.

Svatek RS, Karam J, Karakiewicz PI, Gallina A, Casella R, Roehrborn CG, Shariat SF. Svatek RS, et al. J Urol. 2008 Feb;179(2):478-84; discussion 484. doi: 10.1016/j.juro.2007.09.037. J Urol. 2008. PMID: 18076936

7

p53 predictive value for pT1-2 N0 disease at radical cystectomy.

Shariat SF, Lotan Y, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Müller SC, Karam JA, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Cote RJ. Shariat SF, et al. Among authors: karam ja. J Urol. 2009 Sep;182(3):907-13. doi: 10.1016/j.juro.2009.05.024. Epub 2009 Jul 17. J Urol. 2009. PMID: 19616250

8

Growing teratoma syndrome.

Karam JA, Raj GV. Karam JA, et al. Urology. 2009 Oct;74(4):783-4. doi: 10.1016/j.urology.2009.03.026. Epub 2009 Aug 3. Urology. 2009. PMID: 19647298

9

Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81.

Shariat SF, Karam JA, Karakiewicz PI. Shariat SF, et al. Among authors: karam ja. Eur Urol. 2009 Jan;55(1):250-2. doi: 10.1016/j.eururo.2008.09.037. Eur Urol. 2009. PMID: 20050019 No abstract available.

10

Editorial comment.

Karam JA, Wood CG. Karam JA, et al. J Urol. 2010 Mar;183(3):870; discussion 870. doi: 10.1016/j.juro.2009.11.080. Epub 2010 Jan 18. J Urol. 2010. PMID: 20083268 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters